The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions

October 1997

The withdrawal of Redux (dexfenfluramine) and Pondimin (fenfluramine) leaves lots of unanswered questions.

How many patients might have heart valve problems...who should get an ECHO...and whether these problems are reversible.

Researchers now suggest that 30% of patients on Redux or Pondimin might have leaky heart valves.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

Cutting-edge advice about new medications and how they fit into practice
Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote